HUTCHMED Statistics
Want to see HCM full AI Analyst Report?
HUTCHMED (HCM) Stock Statistics & Valuation Metrics
Total Valuation
HUTCHMED has a market cap or net worth of $2.65B. The enterprise value is $612.26M.
- Market Cap
- $2.65B
- Enterprise Value
- $612.26M
Share Statistics
HUTCHMED has 174,467,030 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 174,467,030
- Owned by Insiders
- ―
- Owned by Institutions
- 0.56%
Financial Efficiency
HUTCHMED’s return on equity (ROE) is 0.37 and return on invested capital (ROIC) is -3.28%.
- Return on Equity (ROE)
- 0.37
- Return on Assets (ROA)
- 0.26
- Return on Invested Capital (ROIC)
- -3.28%
- Return on Capital Employed (ROCE)
- -0.04
- Revenue Per Employee
- 306.22K
- Profits Per Employee
- 255.08K
- Employee Count
- 1,796
- Asset Turnover
- 0.31
- Inventory Turnover
- 8.20
Valuation Ratios
The current PE Ratio of HUTCHMED is 162.90. HUTCHMED’s PEG ratio is -1.69.
- PE Ratio
- 162.90
- PS Ratio
- 4.77
- PB Ratio
- 2.07
- Price to FCF
- 263.25
- Price to Operating Cash Flow
- 127.53
- PEG Ratio
- -1.69
Income Statement
In the last 12 months, HUTCHMED had revenue of 549.96M and earned 458.12M in profits. Earnings per share was 2.65.
- Revenue
- 549.96M
- Gross Profit
- 212.72M
- Operating Income
- -54.73M
- Pretax Income
- 522.72M
- Net Income
- 458.12M
- EBITDA
- -41.42M
- Earnings Per Share (EPS)
- 2.65
Cash Flow
In the last 12 months, operating cash flow was 20.46M and capital expenditures -10.51M, giving a free cash flow of 9.95M billion.
- Operating Cash Flow
- 20.46M
- Free Cash Flow
- 9.95M
- Free Cash Flow per Share
- 0.06
Dividends & Yields
HUTCHMED pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.38%
- Earnings Yield
- 0.69%
Stock Price Statistics
- Beta
- 0.47
- 52-Week Price Change
- -2.81%
- 50-Day Moving Average
- 13.97
- 200-Day Moving Average
- 13.15
- Relative Strength Index (RSI)
- 57.63
- Average Volume (3m)
- 69.99K
Important Dates
HUTCHMED upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Jul 30, 2026
- Next Earnings Date
- Mar 04, 2027
- Ex-Dividend Date
- ―
Financial Position
HUTCHMED as a current ratio of 4.96, with Debt / Equity ratio of 7.91%
- Current Ratio
- 4.96
- Quick Ratio
- 4.83
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- -0.64
- Interest Coverage Ratio
- -19.05
Taxes
In the past 12 months, HUTCHMED has paid 63.78M in taxes.
- Income Tax
- 63.78M
- Effective Tax Rate
- 0.12
Enterprise Valuation
HUTCHMED EV to EBITDA ratio is -127.08, with an EV/FCF ratio of 262.04.
- EV to Sales
- 4.75
- EV to EBITDA
- -127.08
- EV to Free Cash Flow
- 262.04
- EV to Operating Cash Flow
- 127.42
Balance Sheet
HUTCHMED has $1.38B in cash and marketable securities with $94.51M in debt, giving a net cash position of $1.28B billion.
- Cash & Marketable Securities
- $1.38B
- Total Debt
- $94.51M
- Net Cash
- $1.28B
- Net Cash Per Share
- $7.35
- Tangible Book Value Per Share
- $7.36
Margins
Gross margin is 0.20%, with operating margin of -6.33%, and net profit margin of 3.26%.
- Gross Margin
- 0.20%
- Operating Margin
- -6.33%
- Pretax Margin
- 3.66%
- Net Profit Margin
- 3.26%
- EBITDA Margin
- -3.74%
- EBIT Margin
- -6.33%
Analyst Forecast
The average price target for HUTCHMED is $18.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $18.25
- Price Target Upside
- 22.90% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- -8.81%
- EPS Growth Forecast
- -96.21%
Scores
- Smart Score
- 5
- AI Score
- 53
